PROVIDER PROFILE · NPI 1265540678

Horidel FeboM.D.

EndocrinologySan Juan, PRI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$5K

Peer benchmark

Total Medicare services vs. 86 Endocrinology providers in PR — below median (cohort median 88).

PRESCRIBING · PART D · 2024

Total Rx claims

4,585

Beneficiaries

—

Total drug cost

$914K

Distinct drugs

Brand share

64.7%

Top prescribed drugs

Levothyroxine Sodium1,115 claims

Metformin Hcl545 claims

Rosuvastatin Calcium485 claims

Losartan Potassium180 claims

Glipizide167 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$555

Payment records

By payment type

Food and Beverage$555

REFERRAL NETWORK

Where Horidel Febo's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
LABORATORIO CLINICO C L A INC	11	35

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
HOSPITAL ESPANOL AUXILIO MUTUO DE PUERTO RICO, INC.	12	14
Laboratorio Clinico Borinquen, Inc Clinical Laboratory · Caguas, PR	11	15

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history